Chemo Espana SA-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013111)
◆英語タイトル:Chemo Espana SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013111
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:43
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Chemo Espana SA (Chemo Group) is a pharmaceutical company, which conducts research, development, manufacture, sales and marketing of active pharmaceutical ingredients (APIs), finished dosage forms and branded pharmaceuticals. Its product portfolio includes steroids, hormones and antibiotics in different formulations such as tablets, capsules, injectables and suspensions. The company’s target therapy areas include cardiovascular, gastroenterology, anti-infective, central nervous system, respiratory, women’s healthcare, endocrinology, dermatology and urology. Chemo Group’s OTC division develops food supplements in the form of soft gel capsules, hard capsules, tablets, pellets, sachets to cosmetics covering metabolic syndrome, digestive disorders, women and men healthcare, weigh control or quality of life. It has presence in Europe, South America, Asia and North America. Chemo Group is headquartered in Madrid, Spain.

Chemo Espana SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Chemo Espana SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Chemo Espana SA, Medical Devices Deals, 2011 to YTD 2017 11
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Chemo Espana SA, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Exeltis Acquires Juste Farma Division from Juste labs 14
Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 15
Partnerships 16
SMS Pharma Plans to Form Joint Venture with Chemo 16
IntelGenx Enters into Co-Development Agreement with Chemo 17
mAbxience Partners with World Health Organization and Utrecht Centre of Excellence for Affordable Biotherapeutics for Public Health 18
EPIRUS Biopharma Enters into Distribution Agreement with mAbxience 19
Natco Pharma Enters Into Agreement With MAbxience For Monoclonal Antibodies 20
GH Genhelix Enters Into Co-Promotion Agreement With Toyota Tsusho 21
Licensing Agreements 22
Exeltis Enters into Licensing Agreement with Neurim Pharma 22
Chemo Enters into Licensing Agreement with IntelGenx 23
Stada Arzneimittel to Enter into Licensing Agreement with mAbxience 24
Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 25
Acquisition 26
Exeltis Acquires Embil Pharma 26
mAbxience Acquires GH Genhelix for USD13.5 Million 27
Exeltis Acquires Althea Pharma 28
Everett Labs Acquires Quinnova Pharma From AmDerma Pharma 29
Chemo Espana Acquires 75% Stake In Nufarindo 30
Chemo Group Completes Acquisition Of 60% Stake In Ordain Health Care 31
Chemo Group Acquires 50% Stake In Laboratorios de Productos Eticos 32
Chemo Group Acquires Remaining 50% Joint Venture Stake In Servicios Elche 33
Chemo Group Acquires Remaining 50% Joint Venture Stake In Laboratorios Elea Mexico 34
Chemo Group Acquires Remaining 50% Stake In Sinensix Pharma (Thailand) 35
Chemo Espana SA – Key Competitors 36
Chemo Espana SA – Key Employees 37
Chemo Espana SA – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Affiliate 41
Joint Venture 41
Recent Developments 42
Legal and Regulatory 42
Jan 07, 2016: Chemo renews the ISO 14001 environmental certificate of its Laboratorios Liconsa pharmaceutical plant in Azuqueca de Henares 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Chemo Espana SA, Pharmaceuticals & Healthcare, Key Facts 2
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Chemo Espana SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Chemo Espana SA, Deals By Therapy Area, 2011 to YTD 2017 9
Chemo Espana SA, Medical Devices Deals, 2011 to YTD 2017 11
Chemo Espana SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Exeltis Acquires Juste Farma Division from Juste labs 14
Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 15
SMS Pharma Plans to Form Joint Venture with Chemo 16
IntelGenx Enters into Co-Development Agreement with Chemo 17
mAbxience Partners with World Health Organization and Utrecht Centre of Excellence for Affordable Biotherapeutics for Public Health 18
EPIRUS Biopharma Enters into Distribution Agreement with mAbxience 19
Natco Pharma Enters Into Agreement With MAbxience For Monoclonal Antibodies 20
GH Genhelix Enters Into Co-Promotion Agreement With Toyota Tsusho 21
Exeltis Enters into Licensing Agreement with Neurim Pharma 22
Chemo Enters into Licensing Agreement with IntelGenx 23
Stada Arzneimittel to Enter into Licensing Agreement with mAbxience 24
Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 25
Exeltis Acquires Embil Pharma 26
mAbxience Acquires GH Genhelix for USD13.5 Million 27
Exeltis Acquires Althea Pharma 28
Everett Labs Acquires Quinnova Pharma From AmDerma Pharma 29
Chemo Espana Acquires 75% Stake In Nufarindo 30
Chemo Group Completes Acquisition Of 60% Stake In Ordain Health Care 31
Chemo Group Acquires 50% Stake In Laboratorios de Productos Eticos 32
Chemo Group Acquires Remaining 50% Joint Venture Stake In Servicios Elche 33
Chemo Group Acquires Remaining 50% Joint Venture Stake In Laboratorios Elea Mexico 34
Chemo Group Acquires Remaining 50% Stake In Sinensix Pharma (Thailand) 35
Chemo Espana SA, Key Competitors 36
Chemo Espana SA, Key Employees 37
Chemo Espana SA, Other Locations 38
Chemo Espana SA, Subsidiaries 39
Chemo Espana SA, Affiliate 41
Chemo Espana SA, Joint Venture 41

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Chemo Espana SA-製薬・医療分野:企業M&A・提携分析(Chemo Espana SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆